Home/Filings/4/0001144204-18-009411
4//SEC Filing

Miller Larry Lee 4

Accession 0001144204-18-009411

CIK 0001069899other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:14 PM ET

Size

9.0 KB

Accession

0001144204-18-009411

Insider Transaction Report

Form 4
Period: 2018-02-14
Miller Larry Lee
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2018-02-14$11.83/sh+17,928$212,08817,928 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2018-02-1417,9280 total
    Exercise: $11.83From: 2012-03-01Exp: 2019-02-28Class A Common Stock (17,928 underlying)
  • Sale

    Class A Common Stock

    2018-02-14$35.19/sh17,928$630,8860 total
Footnotes (2)
  • [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.73 to $35.60, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001603584

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:14 PM ET
Size
9.0 KB